Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-773
Closed -$485K 1034
2023
Q1
$485K Sell
773
-930
-55% -$593K ﹤0.01% 925
2022
Q4
$953K Buy
+1,703
New +$1.03M ﹤0.01% 881
2022
Q3
Sell
-1,093
Closed -$687K 1083
2022
Q2
$687K Sell
1,093
-895
-45% -$585K ﹤0.01% 1002
2022
Q1
$1.42M Sell
1,988
-1,547
-44% -$1.06M 0.01% 932
2021
Q4
$2.49M Buy
3,535
+1,222
+53% +$879K 0.01% 809
2021
Q3
$1.61M Buy
+2,313
New +$1.54M 0.01% 851
2021
Q2
Sell
-1,838
Closed -$1.18M 996
2021
Q1
$1.18M Sell
1,838
-141
-7% -$93.5K 0.01% 871
2020
Q4
$1.27M Sell
1,979
-1,604
-45% -$997K 0.01% 824
2020
Q3
$2.24M Sell
3,583
-25
-0.7% -$16.1K 0.01% 732
2020
Q2
$2.3M Sell
3,608
-2,079
-37% -$1.36M 0.01% 693
2020
Q1
$3.7M Buy
5,687
+3,053
+116% +$2.09M 0.03% 539
2019
Q4
$1.98M Buy
+2,634
New +$1.99M 0.01% 725

Other funds holding ATRI

Aviva's ATRI Position: Q2 2023 in Review

Aviva sold out of Atrion Corp (ATRI) in Q2 2023, closing a stake of 773 shares — an estimated $485K sold.

Aviva first reported a position in ATRI in Q4 2019 and held it in 12 quarters. The position peaked at $3.7M in Q1 2020. 119 funds tracked by Wall St. Rank hold ATRI as of Q2 2023.

  • Aviva reported no remaining Atrion Corp position as of Q2 2023 after selling out during the quarter.
  • Aviva sold 773 Atrion Corp shares in Q2 2023, an estimated $485K.
  • Aviva first reported a position in Atrion Corp in Q4 2019 and held it in 12 quarters.
  • Aviva's Atrion Corp position peaked at $3.7M in Q1 2020.
  • 119 funds tracked by Wall St. Rank held Atrion Corp as of Q2 2023.

Based on Aviva's 13F filing for Q2 2023, filed 10 Aug 2023.